z-logo
Premium
Conservative surgery and postoperative radiotherapy in 300 adults with soft‐tissue sarcomas
Author(s) -
Lindberg Robert D.,
Martin Richard G.,
Romsdahl Marvin M.,
Barkley H. Thomas
Publication year - 1981
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19810515)47:10<2391::aid-cncr2820471012>3.0.co;2-b
Subject(s) - medicine , radiation therapy , surgery , soft tissue , lesion , soft tissue sarcoma , radical surgery , lymph node , stage (stratigraphy) , incidence (geometry) , survival rate , fibrosarcoma , lymphatic system , conservative treatment , cancer , pathology , paleontology , physics , optics , biology
From January 1963 through December 1977, 300 adults with soft‐tissue sarcomas were treated by a conservative surgical excision and postoperative radiotherapy. The absolute two‐ and five‐year disease‐free survival rates are 74% (222/300) and 61.3% (103/168), respectively. The five‐year survival rate varies with: (1) anatomic site, e.g. , 69.4% (75/108) for extremity lesions vs. 33% (5/15) for abdominal lesions; (2) histopathologic diagnosis, e.g. , 86.4% (19/22) for fibrosarcoma vs. 50% (15/30) for neurofibrosarcoma; and (3) stage of the lesion. The overall local recurrence rate was 22.3% (67/300) and 27% (81/300) of the patients developed distant metastases. The incidence of lymph node metastases as an initial site of spread was only 2.7% (8/300); therefore, elective treatment of the regional lymphatics is not indicated. The 6.5% incidence of significant complications in extremities is low and might be further diminished by careful treatment planning. The combination of conservative surgery and postoperative radiation therapy maintains a functional limb in 84.5% (169/200) of patients with extremity lesions. This rate is comparable to the five‐year survival rate attained with radical surgery.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here